Benjamin Guy Davis

Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France.

Founded in 1935, Glaxo Group Ltd. is a subsidiary of GSK Plc. The company is based in Middlesex, UK. At GSK, we unite science, technology and talent to get ahead of disease together.

Intouch with Health Ltd. delivers IT-based patient flow management solutions to help hospitals and private healthcare providers. Its solutions include calling, wait time manager, hospital wayfinding, flow manager, patient activity manager, and performance manager. The company was founded by Rohit Sethi and Paul Blackburn in 1999 and is headquartered in Cirencester, the United Kingdom.

Sitka Partners Ltd. engages in growth capital investments. The company is based in LO.

Laboratoire Glaxosmithkline SAS manufactures pharmaceutical products. The company was founded in 2001 and is headquartered in Rueil-Malmaison, France.

Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ.

Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France.

Sygnature Discovery Ltd. engages in drug discovery activities. It specializes in target validation, hit identification, hit to lead, lead optimization, integrated drug discovery, and fragment based drug discovery. The company was founded by Simon Christopher Hirst in 2004 and is headquartered in Nottingham, United Kingdom.

Altacor Ltd. operates as a specialist ophthalmology company develops and markets a portfolio of products in the fields of dry eye, glaucoma and ocular infection. The company was founded by Francesca Elizabeth Crawford and David Francis Alcraft in 2007 and is headquartered in Theale, the United Kingdom.

Optasia Medical Ltd. develops novel imaging productivity tools. Its products are SpineAnalyzer and KneeTool that help to make a more accurate diagnosis, provide meaningful monitoring. The company was founded in 2006 by Alan Brett and is headquartered in Cheadle, the United Kingdom.

Amati Global Investors Ltd. (Venture Capital) is a Venture Capital firm, a subsidiary of Amati Global Investors Ltd. founded in 1999. The firm is headquartered in Edinburgh.

Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.

Janssen-Cilag Ltd. provides pharmaceutical products and services. It offers medicines that can treat serious health conditions such as schizophrenia, epilepsy, multiple myeloma, and human immunodeficiency virus/acquired immunodeficiency syndrome. The firm's other key areas of activity include pain management, gastroenterology, fungal infections, women’s health, neurology, and anaemia. The company was founded on October 19, 1971 and is headquartered in High Wycombe, the United Kingdom.

Netherlands Translational Research Center BV develops small molecule drug leads and preclinical candidates for cancer, autoimmune and Parkinson diseases. Its product NFK GreenScreen plays an important role in immune modulation and neurodegenerative disease. The firm also offers Oncolines, OncolinesProfiler, SynergyFinder, ResidenceTimer and EntropySelect services. The company was founded by Guido J. R. Zaman and Rogier C. Buijsman in June 2011 and is headquartered in Oss, the Netherlands.

Lamellar Biomedical Ltd. manufactures basic pharmaceutical products. The firm's offers lamellasomes, a synthetic substance that mimics the actions lamellar bodies and provides treatment for respiratory diseases, such as cystic fibrosis. The company was founded in 2006 and is headquartered in Bellshill, the United Kingdom.

BioAscent Discovery Ltd. provides integrated drug discovery services. The firm offers compound management and compound reformatting services. Its products include readymade screening libraries, custom screening libraries and follow-up samples. The company was founded by Sylviane Boucharens in 2013 and is headquartered in Motherwell, the United Kingdom.

The Royal Society of Chemistry is an organization that supports the chemical sciences community in making the world a better place. The Royal Society of Chemistry is based in London, UK, and has subsidiaries in the United Kingdom. The British company offers various opportunities in education, inclusion, and chemistry's ability to tackle challenges. The organization aims to advance excellence, connect chemical scientists, and shape the future of the chemical sciences for the benefit of humanity. The private company has a publishing portfolio that contains over one million articles, chapters, and records from across the chemical sciences and related fields. The company also provides solutions to help businesses engage with their audience of chemical scientists.

CN Bio Innovations Ltd. develops and supplies bioengineered solutions. Its products include liver chip system, tissue flex system, contract research services, drug safety profiling, drug metabolism, bespoke tissue models & applications development and technical support. The company was founded by Dr. Tim Hart on February 28, 2008 and is headquartered in Begbroke, the United Kingdom.

Enhance Biotech, Inc. engages in the acquisition, development and commercialization of drugs for lifestyle disorders. The company was founded on June 7, 1999 and is headquartered in New York, NY.

Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.